» Articles » PMID: 38532960

Detection and Molecular Serotyping With a Customized TaqMan Array Card in the Enterics for Global Health (EFGH): Surveillance Study

Abstract

Background: Quantitative polymerase chain reaction (qPCR) targeting has been proven to be highly efficient in detecting in clinical samples compared to culture-based methods, which underestimate burden by 2- to 3-fold. qPCR assays have also been developed for speciation and serotyping, which is critical for both vaccine development and evaluation.

Methods: The Enterics for Global Health (EFGH) surveillance study will utilize a customized real-time PCR-based TaqMan Array Card (TAC) interrogating 82 targets, for the detection and differentiation of spp, , serotypes, other diarrhea-associated enteropathogens, and antimicrobial resistance (AMR) genes. Total nucleic acid will be extracted from rectal swabs or stool samples, and assayed on TAC. Quantitative analysis will be performed to determine the likely attribution of and other particular etiologies of diarrhea using the quantification cycle cutoffs derived from previous studies. The qPCR results will be compared to conventional culture, serotyping, and phenotypic susceptibility approaches in EFGH.

Conclusions: TAC enables simultaneous detection of diarrheal etiologies, the principal pathogen subtypes, and AMR genes. The high sensitivity of the assay enables more accurate estimation of -attributed disease burden, which is critical to informing policy and in the design of future clinical trials.

Citing Articles

Twenty-five years of sentinel laboratory-based surveillance of shigellosis in a high-income country endemic for the disease, Israel, 1998 to 2022.

Cohen D, Treygerman O, Ken-Dror S, Sagi O, Strauss M, Parizade M Euro Surveill. 2024; 29(31).

PMID: 39092530 PMC: 11295440. DOI: 10.2807/1560-7917.ES.2024.29.31.2400022.


Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH) Surveillance Study.

Vannice K, MacLennan C, Long J, Steele A Open Forum Infect Dis. 2024; 11(Suppl 1):S1-S5.

PMID: 38532964 PMC: 10962720. DOI: 10.1093/ofid/ofad586.


Diarrhea Case Surveillance in the Enterics for Global Health Surveillance Study: Epidemiologic Methods.

Atlas H, Conteh B, Islam M, Jere K, Omore R, Sanogo D Open Forum Infect Dis. 2024; 11(Suppl 1):S6-S16.

PMID: 38532963 PMC: 10962728. DOI: 10.1093/ofid/ofad664.


Quantifying the Cost of Diarrhea in the Enterics for Global Health (EFGH) Surveillance Study.

Morozoff C, Ahmed N, Chinkhumba J, Islam M, Jallow A, Ogwel B Open Forum Infect Dis. 2024; 11(Suppl 1):S41-S47.

PMID: 38532961 PMC: 10962725. DOI: 10.1093/ofid/ofad575.


Exploring Natural Immune Responses to Exposure Using Multiplex Bead Assays on Dried Blood Spots in High-Burden Countries: Protocol From a Multisite Diarrhea Surveillance Study.

Benedicto-Matambo P, Avolio L, Badji H, Batool R, Khanam F, Munga S Open Forum Infect Dis. 2024; 11(Suppl 1):S58-S64.

PMID: 38532958 PMC: 10962721. DOI: 10.1093/ofid/ofad650.


References
1.
Colston J, Francois R, Pisanic N, Penataro Yori P, McCormick B, Paredes Olortegui M . Effects of Child and Maternal Histo-Blood Group Antigen Status on Symptomatic and Asymptomatic Enteric Infections in Early Childhood. J Infect Dis. 2019; 220(1):151-162. PMC: 6548901. DOI: 10.1093/infdis/jiz072. View

2.
Small P . Shigella and Escherichia coli strategies for survival at low pH. Jpn J Med Sci Biol. 1999; 51 Suppl:S81-9. DOI: 10.7883/yoken1952.51.supplement1_s81. View

3.
Liu J, Pholwat S, Zhang J, Taniuchi M, Haque R, Alam M . Evaluation of Molecular Serotyping Assays for Shigella flexneri Directly on Stool Samples. J Clin Microbiol. 2020; 59(2). PMC: 8111134. DOI: 10.1128/JCM.02455-20. View

4.
Lan R, Alles M, Donohoe K, Martinez M, Reeves P . Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp. Infect Immun. 2004; 72(9):5080-8. PMC: 517479. DOI: 10.1128/IAI.72.9.5080-5088.2004. View

5.
Platts-Mills J, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A . Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health. 2015; 3(9):e564-75. PMC: 7328884. DOI: 10.1016/S2214-109X(15)00151-5. View